Y. Jabali

705 total citations
10 papers, 228 citations indexed

About

Y. Jabali is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Hematology. According to data from OpenAlex, Y. Jabali has authored 10 papers receiving a total of 228 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Public Health, Environmental and Occupational Health, 4 papers in Pediatrics, Perinatology and Child Health and 4 papers in Hematology. Recurrent topics in Y. Jabali's work include Acute Lymphoblastic Leukemia research (6 papers), Childhood Cancer Survivors' Quality of Life (4 papers) and Acute Myeloid Leukemia Research (3 papers). Y. Jabali is often cited by papers focused on Acute Lymphoblastic Leukemia research (6 papers), Childhood Cancer Survivors' Quality of Life (4 papers) and Acute Myeloid Leukemia Research (3 papers). Y. Jabali collaborates with scholars based in Czechia, Germany and Hong Kong. Y. Jabali's co-authors include Jan Starý, Václav Smrčka, Vladimír Mihál, Dagmar Pospı́šilová, Jir̆ı́ Petrák, Jana Čmejlová, Radek Čmejla, Eva Froňková, Jan Trka and Ondřej Hrušák and has published in prestigious journals such as Leukemia, Human Mutation and Haematologica.

In The Last Decade

Y. Jabali

10 papers receiving 226 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y. Jabali Czechia 5 100 87 83 50 40 10 228
Jean Hugues Dalle France 6 61 0.6× 38 0.4× 108 1.3× 37 0.7× 11 0.3× 9 198
Peifang Xiao China 6 39 0.4× 28 0.3× 121 1.5× 32 0.6× 16 0.4× 41 175
Maria Grazia Orofino Italy 8 59 0.6× 53 0.6× 235 2.8× 19 0.4× 29 0.7× 12 363
Lena Rai United Kingdom 7 136 1.4× 37 0.4× 144 1.7× 59 1.2× 5 0.1× 8 273
Sharat Chandra United States 11 45 0.5× 31 0.4× 218 2.6× 39 0.8× 22 0.6× 37 343
Péter Reményi Hungary 9 76 0.8× 34 0.4× 144 1.7× 44 0.9× 4 0.1× 36 217
Sigrid Machherndl‐Spandl Austria 8 30 0.3× 87 1.0× 159 1.9× 38 0.8× 19 0.5× 36 248
Samantha Nichele Brazil 6 27 0.3× 52 0.6× 89 1.1× 41 0.8× 13 0.3× 14 152
Shiro Nakayama Japan 5 44 0.4× 41 0.5× 195 2.3× 212 4.2× 21 0.5× 8 329
Concepción Rivas Spain 7 204 2.0× 126 1.4× 262 3.2× 37 0.7× 2 0.1× 18 353

Countries citing papers authored by Y. Jabali

Since Specialization
Citations

This map shows the geographic impact of Y. Jabali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Jabali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Jabali more than expected).

Fields of papers citing papers by Y. Jabali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Jabali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Jabali. The network helps show where Y. Jabali may publish in the future.

Co-authorship network of co-authors of Y. Jabali

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Jabali. A scholar is included among the top collaborators of Y. Jabali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Jabali. Y. Jabali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Sedláček, Petr, Peter Múdrý, Jan Mužı́k, et al.. (2013). Probable/proven invasive aspergillosis in children with malignancy registered in database FIND, Study on behalf of the Czech Leukemia Study Group for life CELL. 1 indexed citations
2.
Mihál, Vladimír, Jaroslav Štěrba, Y. Jabali, et al.. (2011). Minimal residual disease in peripheral blood at day 15 identifies a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with superior prognosis. Haematologica. 96(12). 1815–1821. 14 indexed citations
3.
Mejstříková, Ester, Eva Froňková, Tomáš Kalina, et al.. (2010). Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria. Haematologica. 95(6). 928–935. 42 indexed citations
4.
Čmejla, Radek, Jana Čmejlová, Jir̆ı́ Petrák, et al.. (2009). Identification of mutations in the ribosomal protein L5 (RPL5) and ribosomal protein L11 (RPL11) genes in Czech patients with Diamond-Blackfan anemia. Human Mutation. 30(3). 321–327. 74 indexed citations
5.
Froňková, Eva, Ester Mejstříková, Smadar Avigad, et al.. (2008). Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: is it possible to avoid MRD testing?. Leukemia. 22(5). 989–997. 50 indexed citations
6.
Jabali, Y., et al.. (2005). Rosai-Dorfman Disease: Successful Long-term Results by Combination Chemotherapy with Prednisone, 6-Mercaptopurine, Methotrexate, and Vinblastine: A Case Report. International Journal of Surgical Pathology. 13(3). 285–289. 39 indexed citations
7.
Starý, Jan, Petr Gajdoš, Dagmar Pospı́šilová, et al.. (2003). [Improved results in children with acute lymphoblastic leukemia treated with the ALL-BFM 90 protocol in the Czech Republic].. PubMed. 142(7). 404–9. 3 indexed citations
8.
Starý, Jan, Petr Gajdoš, Hana Hrstková, et al.. (2002). Treatment of Czech children with acute lymphoblastic leukemia: A report of the Czech working group for pediatric hematology. Medical and Pediatric Oncology. 39(2). 125–127. 1 indexed citations
9.
Jabali, Y., et al.. (2000). Acute lymphoblastic leukemia in infants: A decade of experience in the Czech Republic. Medical and Pediatric Oncology. 35(5). 493–495. 1 indexed citations
10.
Chrdle, Aleš, et al.. (1999). Clinical picture of TBE; a retrospective study of 493 cases. Zentralblatt für Bakteriologie. 289(5-7). 583–584. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026